CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Innate Pharma SA (IPHA) Financial Analysis | CapyFin

Innate Pharma SA

IPHA · Euronext Paris🇫🇷

Earnings Dividends Seasonality Metrics

Reported earnings 3 days ago

Previous year: €6.64M

Previous year: -€0.165

Previous year: 9M

Previous year: 2.4M

Cash and Equivalents

Loading...

Innate Pharma SA

Unlock previous datapoints

Innate Pharma SA

Unlock previous datapoints

Innate Pharma SA Revenue by Geographic Location

Revenue by Geographic Location

Global Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$119M

P/E Ratio

-3.40

Sector

N/A

Industry

N/A

52-Week High

$2.05

52-Week Low

$1.08

R&D Expenses

7.8M

G&A Expenses

2.6M